<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Hypoxic-ischemic (HI) brain injury in infants is a leading cause of lifelong disability </plain></SENT>
<SENT sid="1" pm="."><plain>We report a novel pathway mediating oxidative brain injury after <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in which C1q plays a central role </plain></SENT>
<SENT sid="2" pm="."><plain>Neonatal mice incapable of classical or terminal complement activation because of C1q or C6 deficiency or pharmacologically inhibited assembly of membrane attack complex were subjected to <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Only C1q(-/-) mice exhibited neuroprotection coupled with attenuated oxidative brain injury </plain></SENT>
<SENT sid="4" pm="."><plain>This was associated with reduced production of reactive oxygen species (ROS) in C1q(-/-) brain mitochondria and preserved activity of the respiratory chain </plain></SENT>
<SENT sid="5" pm="."><plain>Compared with C1q(+/+) neurons, cortical C1q(-/-) neurons exhibited resistance to oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation </plain></SENT>
<SENT sid="6" pm="."><plain>However, postischemic exposure to exogenous C1q increased both <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> ROS production and mortality of C1q(-/-) neurons </plain></SENT>
<SENT sid="7" pm="."><plain>This C1q toxicity was abolished by coexposure to <z:chebi fb="11" ids="22586">antioxidant</z:chebi> Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-<z:chebi fb="1" ids="33575">carboxylic acid</z:chebi>) </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, the C1q component of complement, accelerating <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> ROS emission, exacerbates oxidative injury in the developing HI brain </plain></SENT>
<SENT sid="9" pm="."><plain>The terminal complement complex is activated in the HI neonatal brain but appeared to be nonpathogenic </plain></SENT>
<SENT sid="10" pm="."><plain>These findings have important implications for design of the proper therapeutic interventions against HI neonatal brain injury by highlighting a pathogenic priority of C1q-mediated <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:mp ids='MP_0003674'>oxidative stress</z:mp> over the C1q deposition-triggered terminal complement activation </plain></SENT>
</text></document>